Bain Capital Specialty Finance, Inc. 10-Q Filing

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share BCSF New York Stock Excha

Filing Documents

• bcsf-20240930.htm (10-Q) — 23560KB
• bcsf-ex31_1.htm (EX-31.1) — 22KB
• bcsf-ex31_2.htm (EX-31.2) — 22KB
• bcsf-ex32.htm (EX-32) — 11KB
• 0000950170-24-121464.txt ( ) — 66960KB
• bcsf-20240930.xsd (EX-101.SCH) — 2841KB
• bcsf-20240930_htm.xml (XML) — 20067KB

Notes to Consolidated Financial Statements (unaudited)

Notes to Consolidated Financial Statements (unaudited) 44 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 114 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 133 Item 4.

Controls and Procedures

Controls and Procedures 134 PART II OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 134 Item 1A.

Risk Factors

Risk Factors 134 Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities 134 Item 3. Default Upon Senior Securities 134 Item 4. Mine Safety Disclosures 134 Item 5. Other Information 135 Item 6. Exhibits, Financial Statement Schedules 136

Signatures

Signatures 141 i

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS Although we believe that the assumptions on which these forward-looking statements are based are reasonable, some of those assumptions may be based on the work of third parties and any of those a

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Consolidated Financial Statements

Item 1. Consolidated Financial Statements Bain Capital Specialty Finance, Inc. Consolidated Statements of Assets and Liabilities (in thousands, except share and per share data) As of As of September 30, 2024 December 31, 2023 (Unaudited) Assets Investments at fair value: Non-controlled/non-affiliate investments (amortized cost of $ 1,759,021 and $ 1,615,061 , respectively) $ 1,754,245 $ 1,593,360 Non-controlled/affiliate investment (amortized cost of $ 75,517 and $ 132,650 , respectively) 80,035 147,971 Controlled affiliate investment (amortized cost of $ 578,475 and $ 554,123 , respectively) 573,670 557,012 Cash and cash equivalents 25,336 42,995 Foreign cash (cost of $ 4,657 and $ 6,865 , respectively) 5,125 6,405 Restricted cash and cash equivalents 29,292 63,084 Collateral on forward currency exchange contracts 9,675 7,613 Deferred financing costs 4,855 2,802 Interest receivable on investments 34,520 37,169 Receivable for sales and paydowns of investments 17,873 4,310 Prepaid insurance 383 210 Dividend receivable 8,673 9,417 Total Assets $ 2,543,682 $ 2,472,348 Liabilities Debt (net of unamortized debt issuance costs of $ 5,592 and $ 7,567 , respectively) $ 1,300,607 $ 1,255,933 Interest payable 13,170 13,283 Payable for investments purchased 17,280 11,453 Unrealized depreciation on forward currency exchange contracts 6,549 2,260 Base management fee payable 8,897 8,929 Incentive fee payable 7,020 7,327 Accounts payable and accrued expenses 14,518 9,581 Distributions payable 29,053 27,116 Total Liabilities 1,397,094 1,335,882 Commitments and Contingencies (See Note 10) Net Assets Common stock, par value $ 0.001 per share, 100,000,000,000 and 100,000,000,000 shares authorized, 64,562,265 and 64,562,265 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 6

View Full Filing

View this 10-Q filing on SEC EDGAR